ALKS FY 2012 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$576M+47.6% YoY

Gross Profit

$405M70.4% margin

Operating Income

$82M14.2% margin

Net Income

$25M4.3% margin

EPS (Diluted)

$0.18

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$19M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$581M

Stockholders' Equity

$854M

Cash & Equivalents

$84M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$576M	$390M	+47.6%
Gross Profit	$405M	$262M	+54.4%
Operating Income	$82M	-$88M	+192.7%
Net Income	$25M	-$114M	+122.0%